Hein, Martin
Vukmirovic, Aleksandar
Constable, Ian J.
Raja, Vignesh
Athwal, Arman
Freund, K. Bailey
Balaratnasingam, Chandrakumar
Article History
Received: 8 February 2023
Accepted: 16 May 2023
First Online: 19 May 2023
Competing interests
: C. Balaratnasingam is a consultant to and has served on the advisory board for Allergan, Bayer, Novartis and Roche pharmaceuticals. He receives research support from Bayer.- K. B. Freund is a consultant for Allergan, Bayer, Genentech, Heidelberg Engineering and Zeiss. He receives research support from Genentech/Roche. The other authors have no conflicting interests to disclose.